| Year |
Citation |
Score |
| 2022 |
Yost JG, Browne CA, Lucki I. (2R,6R)-hydroxynorketamine (HNK) reverses mechanical hypersensitivity in a model of localized inflammatory pain. Neuropharmacology. 109276. PMID 36198332 DOI: 10.1016/j.neuropharm.2022.109276 |
0.644 |
|
| 2022 |
Namchuk AB, Lucki I, Browne CA. Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder. Advances in Drug and Alcohol Research. 2. PMID 36177442 DOI: 10.3389/adar.2022.10254 |
0.667 |
|
| 2022 |
Yost JG, Wulf HA, Browne CA, Lucki I. . The Journal of Pharmacology and Experimental Therapeutics. PMID 35779947 DOI: 10.1124/jpet.122.001278 |
0.684 |
|
| 2022 |
Wulf HA, Browne CA, Zarate CA, Lucki I. Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors. Psychopharmacology. PMID 35459958 DOI: 10.1007/s00213-022-06118-4 |
0.7 |
|
| 2021 |
Browne CA, Hildegard A Wulf BA, Jacobson ML, Oyola M, Wu TJ, Lucki I. Long-term increase in sensitivity to ketamine's behavioral effects in mice exposed to mild blast induced traumatic brain injury. Experimental Neurology. 113963. PMID 34968423 DOI: 10.1016/j.expneurol.2021.113963 |
0.677 |
|
| 2021 |
Kostelnik C, Lucki I, Choi KH, Browne CA. Translational relevance of fear conditioning in rodent models of mild traumatic brain injury. Neuroscience and Biobehavioral Reviews. PMID 33961927 DOI: 10.1016/j.neubiorev.2021.04.037 |
0.649 |
|
| 2021 |
Browne CA, Wulf H, Lucki I. Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder. Handbook of Experimental Pharmacology. PMID 33580854 DOI: 10.1007/164_2020_432 |
0.702 |
|
| 2020 |
Jacobson ML, Wulf HA, Browne CA, Lucki I. The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice. Psychopharmacology. PMID 32894343 DOI: 10.1007/s00213-020-05649-y |
0.706 |
|
| 2020 |
Jacobson ML, Wulf HA, Tsuda MC, Browne CA, Lucki I. Sex differences in the modulation of mouse nest building behavior by kappa opioid receptor signaling. Neuropharmacology. 108254. PMID 32726598 DOI: 10.1016/j.neuropharm.2020.108254 |
0.717 |
|
| 2020 |
Browne CA, Smith T, Lucki I. Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression. European Journal of Pharmacology. 172948. PMID 31991139 DOI: 10.1016/j.ejphar.2020.172948 |
0.723 |
|
| 2020 |
Jacobson ML, Browne CA, Lucki I. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders. Annual Review of Pharmacology and Toxicology. 60: 615-636. PMID 31914893 DOI: 10.1146/annurev-pharmtox-010919-023317 |
0.686 |
|
| 2020 |
Browne CA, Jacobson ML, Lucki I. Novel Targets to Treat Depression: Opioid-Based Therapeutics. Harvard Review of Psychiatry. 28: 40-59. PMID 31913981 DOI: 10.1097/HRP.0000000000000242 |
0.705 |
|
| 2020 |
Jacobson ML, Simmons SC, Wulf HA, Cheng H, Feng Y, Nugent FS, Browne CA, Lucki I. Protracted Effects of Ketamine Require Immediate Kappa Opioid Receptor Activation and Long‐Lasting Desensitization The Faseb Journal. 34: 1-1. DOI: 10.1096/fasebj.2020.34.s1.04214 |
0.668 |
|
| 2020 |
Kaminsky Z, Longley M, Rosoff D, Luo A, Sun H, Hodgkinson C, Goldman D, Schwandt M, Lucki I, Browne C, Lee J, Charlet K, Muench C, Lohoff F. Epigenome-Wide Association Study of Individuals With Alcohol Use Disorder and Suicidal Behavior: Identification and Replication of TIMP2 as Novel Target Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.132 |
0.665 |
|
| 2019 |
Robinson SA, Hill-Smith TE, Lucki I. Buprenorphine prevents stress-induced blunting of nucleus accumbens dopamine response and approach behavior to food reward in mice. Neurobiology of Stress. 11: 100182. PMID 31304200 DOI: 10.1016/j.ynstr.2019.100182 |
0.794 |
|
| 2019 |
Browne CA, Lucki I. Targeting opioid dysregulation in depression for the development of novel therapeutics. Pharmacology & Therapeutics. PMID 31051197 DOI: 10.1016/j.pharmthera.2019.04.009 |
0.685 |
|
| 2019 |
Lohoff FW, Carr GV, Brookshire B, Ferraro TN, Lucki I. Deletion of the vesicular monoamine transporter 1 (vmat1/slc18a1) gene affects dopamine signaling. Brain Research. PMID 30685272 DOI: 10.1016/j.brainres.2019.01.029 |
0.799 |
|
| 2018 |
Browne CA, Hammack R, Lucki I. Dysregulation of the Lateral Habenula in Major Depressive Disorder. Frontiers in Synaptic Neuroscience. 10: 46. PMID 30581384 DOI: 10.3389/fnsyn.2018.00046 |
0.687 |
|
| 2018 |
Shepard RD, Langlois LD, Browne CA, Berenji A, Lucki I, Nugent FS. Ketamine Reverses Lateral Habenula Neuronal Dysfunction and Behavioral Immobility in the Forced Swim Test Following Maternal Deprivation in Late Adolescent Rats. Frontiers in Synaptic Neuroscience. 10: 39. PMID 30425634 DOI: 10.3389/Fnsyn.2018.00039 |
0.7 |
|
| 2018 |
Jacobson ML, Wulf HA, Browne CA, Lucki I. Opioid modulation of cognitive impairment in depression. Progress in Brain Research. 239: 1-48. PMID 30314565 DOI: 10.1016/bs.pbr.2018.07.007 |
0.684 |
|
| 2018 |
Authement ME, Langlois LD, Shepard RD, Browne CA, Lucki I, Kassis H, Nugent FS. A role for corticotropin-releasing factor signaling in the lateral habenula and its modulation by early-life stress. Science Signaling. 11. PMID 29511121 DOI: 10.1126/Scisignal.Aan6480 |
0.681 |
|
| 2017 |
Browne CA, Falcon E, Robinson SA, Berton O, Lucki I. Reversal of stress-induced social interaction deficits by buprenorphine. The International Journal of Neuropsychopharmacology. PMID 29020387 DOI: 10.1093/Ijnp/Pyx079 |
0.775 |
|
| 2017 |
Browne CA, Erickson RL, Blendy JA, Lucki I. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism. Neuropharmacology. PMID 28188737 DOI: 10.1016/j.neuropharm.2017.02.005 |
0.707 |
|
| 2017 |
Erickson RL, Browne CA, Lucki I. Hair corticosterone measurement in mouse models of type 1 and type 2 diabetes mellitus. Physiology & Behavior. PMID 28089708 DOI: 10.1016/j.physbeh.2017.01.018 |
0.675 |
|
| 2016 |
Robinson SA, Erickson RL, Browne CA, Lucki I. A role for the mu opioid receptor in the antidepressant effects of buprenorphine. Behavioural Brain Research. PMID 27818236 DOI: 10.1016/j.bbr.2016.10.050 |
0.817 |
|
| 2016 |
Carlin JL, McKee SE, Hill-Smith T, Grissom NM, George R, Lucki I, Reyes TM. Removal of high fat diet after chronic exposure drives binge behavior and dopaminergic dysregulation in female mice. Neuroscience. PMID 27063418 DOI: 10.1016/J.Neuroscience.2016.04.002 |
0.316 |
|
| 2016 |
Falcon E, Browne CA, Leon RM, Fleites VC, Sweeney R, Kirby LG, Lucki I. Antidepressant-Like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26979295 DOI: 10.1038/Npp.2016.38 |
0.814 |
|
| 2016 |
Carlson GC, Lin RE, Chen Y, Brookshire BR, White RS, Lucki I, Siegel SJ, Kim SF. Dexras1 a unique ras-GTPase interacts with NMDA receptor activity and provides a novel dissociation between anxiety, working memory and sensory gating. Neuroscience. PMID 26946266 DOI: 10.1016/j.neuroscience.2016.02.063 |
0.797 |
|
| 2016 |
Robinson SA, Brookshire BR, Lucki I. Corticosterone exposure augments sensitivity to the behavioral and neuroplastic effects of fluoxetine in C57BL/6 mice. Neurobiology of Stress. 3: 34-42. PMID 26844246 DOI: 10.1016/j.ynstr.2015.12.005 |
0.817 |
|
| 2015 |
Snyder KP, Hill-Smith TE, Lucki I, Valentino RJ. Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25865931 DOI: 10.1038/npp.2015.98 |
0.624 |
|
| 2015 |
Browne CA, van Nest DS, Lucki I. Antidepressant-like effects of buprenorphine in rats are strain dependent. Behavioural Brain Research. 278: 385-92. PMID 25453747 DOI: 10.1016/j.bbr.2014.10.014 |
0.738 |
|
| 2015 |
Falcon E, Maier K, Robinson SA, Hill-Smith TE, Lucki I. Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice. Psychopharmacology. 232: 907-15. PMID 25178815 DOI: 10.1007/S00213-014-3723-Y |
0.804 |
|
| 2015 |
Ho N, Brookshire BR, Clark JE, Lucki I. Indomethacin reverses decreased hippocampal cell proliferation in streptozotocin-induced diabetic mice. Metabolic Brain Disease. 30: 555-62. PMID 25160865 DOI: 10.1007/S11011-014-9611-7 |
0.776 |
|
| 2014 |
Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne CA, Kazi H, Bang S, Choi BR, Chen Y, McMullen MF, Kim SF. High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiology of Disease. 67: 79-87. PMID 24686304 DOI: 10.1016/J.Nbd.2014.03.011 |
0.771 |
|
| 2014 |
Santini MA, Balu DT, Puhl MD, Hill-Smith TE, Berg AR, Lucki I, Mikkelsen JD, Coyle JT. D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI. Behavioural Brain Research. 259: 242-6. PMID 24269270 DOI: 10.1016/J.Bbr.2013.11.022 |
0.726 |
|
| 2013 |
Browne CA, Lucki I. Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Frontiers in Pharmacology. 4: 161. PMID 24409146 DOI: 10.3389/fphar.2013.00161 |
0.741 |
|
| 2013 |
Ho N, Sommers MS, Lucki I. Effects of diabetes on hippocampal neurogenesis: links to cognition and depression. Neuroscience and Biobehavioral Reviews. 37: 1346-62. PMID 23680701 DOI: 10.1016/J.Neubiorev.2013.03.010 |
0.511 |
|
| 2013 |
Carlin J, Hill-Smith TE, Lucki I, Reyes TM. Reversal of dopamine system dysfunction in response to high-fat diet. Obesity (Silver Spring, Md.). 21: 2513-21. PMID 23512420 DOI: 10.1002/Oby.20374 |
0.304 |
|
| 2013 |
Featherstone RE, M Tatard-Leitman V, Suh JD, Lin R, Lucki I, Siegel SJ. Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression. Psychopharmacology. 227: 639-49. PMID 23392353 DOI: 10.1007/S00213-013-2997-9 |
0.329 |
|
| 2013 |
Balu DT, Turner JR, Brookshire BR, Hill-Smith TE, Blendy JA, Lucki I. Brain monoamines and antidepressant-like responses in MRL/MpJ versus C57BL/6J mice. Neuropharmacology. 67: 503-10. PMID 23220293 DOI: 10.1016/J.Neuropharm.2012.11.027 |
0.824 |
|
| 2013 |
Multani PK, Hodge R, Estévez MA, Abel T, Kung H, Alter M, Brookshire B, Lucki I, Nall AH, Talbot K, Doyle GA, Lohoff FW. VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination. Neuroscience. 232: 32-44. PMID 23201251 DOI: 10.1016/J.Neuroscience.2012.11.023 |
0.318 |
|
| 2013 |
Lucki I, Falcon E. S.7.2 - DEVELOPMENT OF BUPRENORPHINE FOR TREATMENT-RESISTANT DEPRESSION Behavioural Pharmacology. 24: e8. DOI: 10.1097/01.Fbp.0000434710.06884.36 |
0.625 |
|
| 2012 |
Hodes GE, Brookshire BR, Hill-Smith TE, Teegarden SL, Berton O, Lucki I. Strain differences in the effects of chronic corticosterone exposure in the hippocampus. Neuroscience. 222: 269-80. PMID 22735575 DOI: 10.1016/J.Neuroscience.2012.06.017 |
0.795 |
|
| 2012 |
Espallergues J, Teegarden SL, Veerakumar A, Boulden J, Challis C, Jochems J, Chan M, Petersen T, Deneris E, Matthias P, Hahn CG, Lucki I, Beck SG, Berton O. HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 4400-16. PMID 22457490 DOI: 10.1523/Jneurosci.5634-11.2012 |
0.56 |
|
| 2012 |
Ho N, Balu DT, Hilario MR, Blendy JA, Lucki I. Depressive phenotypes evoked by experimental diabetes are reversed by insulin. Physiology & Behavior. 105: 702-8. PMID 21945451 DOI: 10.1016/J.Physbeh.2011.09.003 |
0.725 |
|
| 2012 |
Balu DT, Carlson GC, Talbot K, Kazi H, Hill-Smith TE, Easton RM, Birnbaum MJ, Lucki I. Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function. Hippocampus. 22: 230-40. PMID 21049487 DOI: 10.1002/Hipo.20887 |
0.643 |
|
| 2011 |
Cohen JW, Louneva N, Han LY, Hodes GE, Wilson RS, Bennett DA, Lucki I, Arnold SE. Chronic corticosterone exposure alters postsynaptic protein levels of PSD-95, NR1, and synaptopodin in the mouse brain. Synapse (New York, N.Y.). 65: 763-70. PMID 21190219 DOI: 10.1002/Syn.20900 |
0.641 |
|
| 2011 |
Cowen PJ, Lucki I. Serotonin revisited. Psychopharmacology. 213: 167-9. PMID 21181118 DOI: 10.1007/s00213-010-2138-7 |
0.303 |
|
| 2011 |
Carr GV, Lucki I. The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology. 213: 265-87. PMID 21107537 DOI: 10.1007/s00213-010-2097-z |
0.778 |
|
| 2011 |
Carr GV, Schechter LE, Lucki I. Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats. Psychopharmacology. 213: 499-507. PMID 20217056 DOI: 10.1007/s00213-010-1798-7 |
0.791 |
|
| 2011 |
Lucki I, Barrett JE, Simansky KJ. John A Harvey Neuropsychopharmacology. 36: 2786-2787. DOI: 10.1038/npp.2011.171 |
0.707 |
|
| 2010 |
Hodes GE, Hill-Smith TE, Lucki I. Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice. Neuroscience Letters. 484: 12-6. PMID 20692322 DOI: 10.1016/J.Neulet.2010.07.084 |
0.703 |
|
| 2010 |
Vucetic Z, Totoki K, Schoch H, Whitaker KW, Hill-Smith T, Lucki I, Reyes TM. Early life protein restriction alters dopamine circuitry. Neuroscience. 168: 359-70. PMID 20394806 DOI: 10.1016/J.Neuroscience.2010.04.010 |
0.322 |
|
| 2010 |
Carr GV, Lucki I. Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats. Psychopharmacology. 210: 295-302. PMID 20369354 DOI: 10.1007/s00213-010-1832-9 |
0.752 |
|
| 2010 |
Carr GV, Bangasser DA, Bethea T, Young M, Valentino RJ, Lucki I. Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 752-63. PMID 19924112 DOI: 10.1038/Npp.2009.183 |
0.794 |
|
| 2010 |
Hodes GE, Hill-Smith TE, Suckow RF, Cooper TB, Lucki I. Sex-specific effects of chronic fluoxetine treatment on neuroplasticity and pharmacokinetics in mice. The Journal of Pharmacology and Experimental Therapeutics. 332: 266-73. PMID 19828877 DOI: 10.1124/Jpet.109.158717 |
0.656 |
|
| 2010 |
Valentino RJ, Lucki I, Van Bockstaele E. Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction. Brain Research. 1314: 29-37. PMID 19800322 DOI: 10.1016/j.brainres.2009.09.100 |
0.625 |
|
| 2010 |
Carr GV, Lucki I. The Role of Serotonin in Depression Handbook of Behavioral Neuroscience. 21: 493-505. DOI: 10.1016/S1569-7339(10)70098-9 |
0.782 |
|
| 2009 |
Savitz J, Lucki I, Drevets WC. 5-HT(1A) receptor function in major depressive disorder. Progress in Neurobiology. 88: 17-31. PMID 19428959 DOI: 10.1016/j.pneurobio.2009.01.009 |
0.436 |
|
| 2009 |
Balu DT, Hodes GE, Anderson BT, Lucki I. Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1764-73. PMID 19177066 DOI: 10.1038/Npp.2008.234 |
0.796 |
|
| 2009 |
Balu DT, Hodes GE, Hill TE, Ho N, Rahman Z, Bender CN, Ring RH, Dwyer JM, Rosenzweig-Lipson S, Hughes ZA, Schechter LE, Lucki I. Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse. Journal of Pharmacological and Toxicological Methods. 59: 100-7. PMID 19121403 DOI: 10.1016/J.Vascn.2008.12.002 |
0.783 |
|
| 2009 |
Balu DT, Lucki I. Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology. Neuroscience and Biobehavioral Reviews. 33: 232-52. PMID 18786562 DOI: 10.1016/J.Neubiorev.2008.08.007 |
0.64 |
|
| 2008 |
Crowley JJ, Lipsky RH, Lucki I, Berrettini WH. Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome. Psychiatric Genetics. 18: 248-51. PMID 18797399 DOI: 10.1097/Ypg.0B013E3283052Ff7 |
0.523 |
|
| 2008 |
Hoshaw BA, Hill TI, Crowley JJ, Malberg JE, Khawaja X, Rosenzweig-Lipson S, Schechter LE, Lucki I. Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission. European Journal of Pharmacology. 594: 109-16. PMID 18675266 DOI: 10.1016/J.Ejphar.2008.07.023 |
0.813 |
|
| 2008 |
Howard O, Carr GV, Hill TE, Valentino RJ, Lucki I. Differential blockade of CRF-evoked behaviors by depletion of norepinephrine and serotonin in rats. Psychopharmacology. 199: 569-82. PMID 18516596 DOI: 10.1007/S00213-008-1179-7 |
0.82 |
|
| 2008 |
Balu DT, Hoshaw BA, Malberg JE, Rosenzweig-Lipson S, Schechter LE, Lucki I. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Research. 1211: 37-43. PMID 18433734 DOI: 10.1016/J.Brainres.2008.03.023 |
0.797 |
|
| 2008 |
Bechtholt AJ, Smith K, Gaughan S, Lucki I. Sucrose intake and fasting glucose levels in 5-HT(1A) and 5-HT(1B) receptor mutant mice. Physiology & Behavior. 93: 659-65. PMID 18155098 DOI: 10.1016/j.physbeh.2007.11.006 |
0.795 |
|
| 2008 |
Bechtholt AJ, Valentino RJ, Lucki I. Overlapping and distinct brain regions associated with the anxiolytic effects of chlordiazepoxide and chronic fluoxetine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2117-30. PMID 17987061 DOI: 10.1038/sj.npp.1301616 |
0.81 |
|
| 2007 |
Gur TL, Conti AC, Holden J, Bechtholt AJ, Hill TE, Lucki I, Malberg JE, Blendy JA. cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 7860-8. PMID 17634380 DOI: 10.1523/Jneurosci.2051-07.2007 |
0.795 |
|
| 2007 |
Malberg JE, Platt B, Rizzo SJ, Ring RH, Lucki I, Schechter LE, Rosenzweig-Lipson S. Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2360-8. PMID 17342171 DOI: 10.1038/Sj.Npp.1301358 |
0.725 |
|
| 2007 |
O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology. 192: 357-71. PMID 17318507 DOI: 10.1007/S00213-007-0728-9 |
0.832 |
|
| 2007 |
Rosenzweig-Lipson S, Sabb A, Stack G, Mitchell P, Lucki I, Malberg JE, Grauer S, Brennan J, Cryan JF, Sukoff Rizzo SJ, Dunlop J, Barrett JE, Marquis KL. Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents. Psychopharmacology. 192: 159-70. PMID 17297636 DOI: 10.1007/S00213-007-0710-6 |
0.817 |
|
| 2007 |
Bechtholt AJ, Hill TE, Lucki I. Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test. Psychopharmacology. 190: 531-40. PMID 17165096 DOI: 10.1007/s00213-006-0615-9 |
0.812 |
|
| 2007 |
O'Leary OF, Bechtholt AJ, Crowley JJ, Valentino RJ, Lucki I. The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 215-26. PMID 16997535 DOI: 10.1016/J.Euroneuro.2006.06.012 |
0.827 |
|
| 2006 |
Hoshaw BA, Evans JC, Mueller B, Valentino RJ, Lucki I. Social competition in rats: cell proliferation and behavior. Behavioural Brain Research. 175: 343-51. PMID 17045347 DOI: 10.1016/J.Bbr.2006.09.004 |
0.793 |
|
| 2006 |
Crowley JJ, Brodkin ES, Blendy JA, Berrettini WH, Lucki I. Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2433-42. PMID 16554742 DOI: 10.1038/Sj.Npp.1301065 |
0.543 |
|
| 2005 |
Crowley JJ, Blendy JA, Lucki I. Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology. 183: 257-64. PMID 16220334 DOI: 10.1007/S00213-005-0166-5 |
0.522 |
|
| 2005 |
Cryan JF, Page ME, Lucki I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology. 182: 335-44. PMID 16001105 DOI: 10.1007/s00213-005-0093-5 |
0.619 |
|
| 2005 |
Cryan JF, Valentino RJ, Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience and Biobehavioral Reviews. 29: 547-69. PMID 15893822 DOI: 10.1016/j.neubiorev.2005.03.008 |
0.767 |
|
| 2005 |
Hoshaw BA, Malberg JE, Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Research. 1037: 204-8. PMID 15777771 DOI: 10.1016/J.Brainres.2005.01.007 |
0.807 |
|
| 2005 |
Jones MD, Lucki I. Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1039-47. PMID 15688089 DOI: 10.1038/sj.npp.1300664 |
0.448 |
|
| 2005 |
Andrews CM, Kung HF, Lucki I. The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens. European Journal of Pharmacology. 508: 123-30. PMID 15680262 DOI: 10.1016/J.Ejphar.2004.12.033 |
0.655 |
|
| 2005 |
Crowley JJ, Lucki I. Opportunities to discover genes regulating depression and antidepressant response from rodent behavioral genetics. Current Pharmaceutical Design. 11: 157-69. PMID 15638756 DOI: 10.2174/1381612053382278 |
0.528 |
|
| 2004 |
Crowley JJ, Jones MD, O'Leary OF, Lucki I. Automated tests for measuring the effects of antidepressants in mice. Pharmacology, Biochemistry, and Behavior. 78: 269-74. PMID 15219767 DOI: 10.1016/J.Pbb.2004.03.014 |
0.796 |
|
| 2004 |
Cryan JF, O'Leary OF, Jin SH, Friedland JC, Ouyang M, Hirsch BR, Page ME, Dalvi A, Thomas SA, Lucki I. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 101: 8186-91. PMID 15148402 DOI: 10.1073/Pnas.0401080101 |
0.823 |
|
| 2004 |
Furlan PM, Kallan MJ, Have TT, Lucki I, Katz I. SSRIs do not cause affective blunting in healthy elderly volunteers. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 12: 323-30. PMID 15126234 DOI: 10.1097/00019442-200405000-00012 |
0.628 |
|
| 2004 |
Lucki I, O'Leary OF. Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs. The Journal of Clinical Psychiatry. 65: 11-24. PMID 15046537 |
0.81 |
|
| 2004 |
Hoshaw B, Evans J, Mueller B, Lucki I. P31 REDUCED NEUROGENESIS BY SUBORDINATE RATS IN SOCIAL COMPETITION Behavioural Pharmacology. 15: A17. DOI: 10.1097/00008877-200409000-00071 |
0.764 |
|
| 2003 |
Thomas E, Pernar L, Lucki I, Valentino RJ. Corticotropin-releasing factor in the dorsal raphe nucleus regulates activity of lateral septal neurons. Brain Research. 960: 201-8. PMID 12505673 DOI: 10.1016/S0006-8993(02)03882-9 |
0.595 |
|
| 2003 |
Page ME, Brown K, Lucki I. Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action. Psychopharmacology. 165: 194-201. PMID 12426668 DOI: 10.1007/s00213-002-1269-x |
0.436 |
|
| 2002 |
Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist. The Journal of Pharmacology and Experimental Therapeutics. 302: 1220-7. PMID 12183683 DOI: 10.1124/Jpet.102.034280 |
0.75 |
|
| 2002 |
Price ML, Kirby LG, Valentino RJ, Lucki I. Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. Psychopharmacology. 162: 406-14. PMID 12172694 DOI: 10.1007/S00213-002-1114-2 |
0.818 |
|
| 2002 |
Page ME, Lucki I. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 237-47. PMID 12093597 DOI: 10.1016/S0893-133X(02)00301-9 |
0.402 |
|
| 2002 |
Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences. 23: 238-45. PMID 12008002 DOI: 10.1016/S0165-6147(02)02017-5 |
0.653 |
|
| 2002 |
Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 3262-8. PMID 11943827 DOI: 10.1523/Jneurosci.22-08-03262.2002 |
0.724 |
|
| 2002 |
Graves L, Dalvi A, Lucki I, Blendy JA, Abel T. Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background. Hippocampus. 12: 18-26. PMID 11918283 DOI: 10.1002/Hipo.10003 |
0.56 |
|
| 2002 |
Cryan JF, Page ME, Lucki I. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. European Journal of Pharmacology. 436: 197-205. PMID 11858799 DOI: 10.1016/S0014-2999(01)01628-4 |
0.614 |
|
| 2002 |
Rittenhouse PA, López-Rubalcava C, Stanwood GD, Lucki I. Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology. 27: 303-18. PMID 11818168 DOI: 10.1016/S0306-4530(01)00052-X |
0.775 |
|
| 2001 |
Furlan PM, Kallan MJ, Ten Have T, Pollock BG, Katz I, Lucki I. Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 9: 429-38. PMID 11739070 DOI: 10.1097/00019442-200111000-00012 |
0.634 |
|
| 2001 |
Furlan PM, DeMartinis N, Schweizer E, Rickels K, Lucki I. Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress. Biological Psychiatry. 50: 254-9. PMID 11522259 DOI: 10.1016/S0006-3223(00)01126-4 |
0.604 |
|
| 2001 |
Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. The Journal of Pharmacology and Experimental Therapeutics. 298: 1101-7. PMID 11504807 |
0.621 |
|
| 2001 |
Knobelman DA, Hen R, Blendy JA, Lucki I. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse. The Journal of Pharmacology and Experimental Therapeutics. 298: 1092-100. PMID 11504806 |
0.815 |
|
| 2001 |
Knobelman DA, Hen R, Lucki I. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. The Journal of Pharmacology and Experimental Therapeutics. 298: 1083-91. PMID 11504805 |
0.823 |
|
| 2001 |
Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. The Journal of Pharmacology and Experimental Therapeutics. 298: 651-7. PMID 11454927 |
0.7 |
|
| 2001 |
Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology. 155: 315-22. PMID 11432695 DOI: 10.1007/S002130100694 |
0.588 |
|
| 2001 |
Andrews CM, Lucki I. Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens. Psychopharmacology. 155: 221-9. PMID 11432683 DOI: 10.1007/S002130100704 |
0.637 |
|
| 2001 |
Mayorga AJ, Lucki I. Limitations on the use of the C57BL/6 mouse in the tail suspension test. Psychopharmacology. 155: 110-2. PMID 11374330 DOI: 10.1007/s002130100687 |
0.349 |
|
| 2001 |
Price ML, Lucki I. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 2833-41. PMID 11306635 DOI: 10.1523/Jneurosci.21-08-02833.2001 |
0.666 |
|
| 2001 |
Furlan P, Pollock B, Katz I, Lucki I. Behavioral effects of paroxetine and sertraline on healthy elderly volunteers European Neuropsychopharmacology. 11: S219-S220. DOI: 10.1016/S0924-977X(01)80212-1 |
0.645 |
|
| 2000 |
Cryan JF, Lucki I. 5-HT4 receptors do not mediate the antidepressant-like behavioral effects of fluoxetine in a modified forced swim test. European Journal of Pharmacology. 409: 295-9. PMID 11108824 DOI: 10.1016/S0014-2999(00)00858-X |
0.683 |
|
| 2000 |
Stanwood GD, Lucki I, McGonigle P. Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments. The Journal of Pharmacology and Experimental Therapeutics. 295: 1232-40. PMID 11082460 |
0.613 |
|
| 2000 |
Stanwood GD, Artymyshyn RP, Kung MP, Kung HF, Lucki I, McGonigle P. Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. The Journal of Pharmacology and Experimental Therapeutics. 295: 1223-31. PMID 11082459 |
0.599 |
|
| 2000 |
Cryan JF, Lucki I. Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. The Journal of Pharmacology and Experimental Therapeutics. 295: 1120-6. PMID 11082448 |
0.627 |
|
| 2000 |
Yang J, Wu J, Kowalska MA, Dalvi A, Prevost N, O'Brien PJ, Manning D, Poncz M, Lucki I, Blendy JA, Brass LF. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proceedings of the National Academy of Sciences of the United States of America. 97: 9984-9. PMID 10954748 DOI: 10.1073/Pnas.180194597 |
0.559 |
|
| 2000 |
Troy SM, Lucki I, Unruh MA, Cevallos WH, Leister CA, Martin PT, Furlan PM, Mangano R. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. Journal of Clinical Psychopharmacology. 20: 328-37. PMID 10831020 DOI: 10.1097/00004714-200006000-00007 |
0.621 |
|
| 2000 |
Knobelman DA, Kung HF, Lucki I. Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors. The Journal of Pharmacology and Experimental Therapeutics. 292: 1111-7. PMID 10688630 |
0.819 |
|
| 2000 |
López-Rubalcava C, Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 191-9. PMID 10649831 DOI: 10.1097/00008877-199711000-00049 |
0.415 |
|
| 2000 |
Lucki I, Cryan JF, Kirby LG, Dalvi A. The role of norepinephrine and serotonin in behavioral models of depression Psychoneuroendocrinology. 25: S23. DOI: 10.1016/S0306-4530(00)90103-3 |
0.798 |
|
| 2000 |
Valentino RJ, Lucki I. Regulation of corticotropin-releasing factor (CRF) neurotransmission in biogenic amine nuclei Psychoneuroendocrinology. 25: S18. DOI: 10.1016/S0306-4530(00)90093-3 |
0.508 |
|
| 1999 |
Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology. 147: 162-7. PMID 10591883 DOI: 10.1007/S002130051156 |
0.837 |
|
| 1999 |
Dalvi A, Lucki I. Murine models of depression. Psychopharmacology. 147: 14-6. PMID 10591858 DOI: 10.1007/S002130051131 |
0.535 |
|
| 1998 |
Kirby LG, Lucki I. The effect of repeated exposure to forced swimming on extracellular levels of 5-hydroxytryptamine in the rat. Stress (Amsterdam, Netherlands). 2: 251-63. PMID 9876256 DOI: 10.3109/10253899809167289 |
0.74 |
|
| 1998 |
Lucki I. The spectrum of behaviors influenced by serotonin. Biological Psychiatry. 44: 151-62. PMID 9693387 DOI: 10.1016/S0006-3223(98)00139-5 |
0.423 |
|
| 1998 |
Price ML, Curtis AL, Kirby LG, Valentino RJ, Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 18: 492-502. PMID 9571657 DOI: 10.1016/S0893-133X(97)00197-8 |
0.822 |
|
| 1998 |
Rénéric JP, Lucki I. Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology. 136: 190-7. PMID 9551776 DOI: 10.1007/s002130050555 |
0.473 |
|
| 1998 |
Kirby LG, Lucki I. EFFECTS OF FLUOXETINE TREATMENT ON EXTRACELLULAR 5-HT AND BEHAVIORAL RESPONSES TO THE FORCED SWIMMINGTEST Behavioural Pharmacology. 9: S49. DOI: 10.1097/00008877-199808000-00100 |
0.697 |
|
| 1997 |
Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behavioural Pharmacology. 8: 523-32. PMID 9832966 DOI: 10.1097/00008877-199711000-00010 |
0.37 |
|
| 1997 |
Kirby LG, Lucki I. Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. The Journal of Pharmacology and Experimental Therapeutics. 282: 967-76. PMID 9262365 |
0.719 |
|
| 1997 |
Kirby LG, Chou-Green JM, Davis K, Lucki I. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Research. 760: 218-30. PMID 9237538 DOI: 10.1016/S0006-8993(97)00287-4 |
0.673 |
|
| 1997 |
Detke MJ, Johnson J, Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Experimental and Clinical Psychopharmacology. 5: 107-12. PMID 9234045 DOI: 10.1037/1064-1297.5.2.107 |
0.672 |
|
| 1997 |
Allen AR, Singh A, Zhuang ZP, Kung MP, Kung HF, Lucki I. The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors. Pharmacology, Biochemistry, and Behavior. 57: 301-7. PMID 9164586 DOI: 10.1016/S0091-3057(96)00339-5 |
0.706 |
|
| 1997 |
Kung MP, Stevenson DA, Plössl K, Meegalla SK, Beckwith A, Essman WD, Mu M, Lucki I, Kung HF. [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. European Journal of Nuclear Medicine. 24: 372-80. PMID 9096087 DOI: 10.1007/Bf00881808 |
0.793 |
|
| 1997 |
Kreiss DS, Lucki I. Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei. Synapse (New York, N.Y.). 25: 107-16. PMID 9021891 DOI: 10.1002/(Sici)1098-2396(199702)25:2<107::Aid-Syn1>3.0.Co;2-G |
0.816 |
|
| 1997 |
L??pez-Rubalcava C, Rittenhouse P, Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test Behavioural Pharmacology. 8: 653. DOI: 10.1097/00008877-199711000-00049 |
0.672 |
|
| 1996 |
Shumsky JS, Lucki I. Differential tolerance to the effects of chlordiazepoxide on unpunished and punished operant responding following chronic treatment. Pharmacology, Biochemistry, and Behavior. 53: 593-601. PMID 8866960 DOI: 10.1016/0091-3057(95)02056-X |
0.686 |
|
| 1996 |
Mercugliano M, Nguyen H, Djali S, Lucki I. Developmental alterations in 5-hydroxytryptamine concentration and turnover after treatment of neonatal rats with 5,7-dihydroxytryptamine. Neurobiology of Learning and Memory. 65: 163-76. PMID 8833105 DOI: 10.1006/nlme.1996.0018 |
0.407 |
|
| 1996 |
Neisewander JL, Lucki I, McGonigle P. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats. Pharmacology, Biochemistry, and Behavior. 53: 935-42. PMID 8801600 DOI: 10.1016/0091-3057(95)02152-3 |
0.32 |
|
| 1996 |
Detke MJ, Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behavioural Brain Research. 73: 43-6. PMID 8788475 DOI: 10.1016/0166-4328(96)00067-8 |
0.662 |
|
| 1996 |
Eberle-Wang K, Lucki I, Chesselet MF. A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesia. Neuroscience. 72: 117-28. PMID 8730711 DOI: 10.1016/0306-4522(95)00548-X |
0.367 |
|
| 1996 |
Lucki I. Serotonin receptor specificity in anxiety disorders. The Journal of Clinical Psychiatry. 57: 5-10. PMID 8647798 |
0.351 |
|
| 1995 |
Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology. 121: 66-72. PMID 8539342 DOI: 10.1007/Bf02245592 |
0.702 |
|
| 1995 |
Detke MJ, Wieland S, Lucki I. Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists. Psychopharmacology. 119: 47-54. PMID 7675949 DOI: 10.1007/Bf02246053 |
0.758 |
|
| 1995 |
Kreiss DS, Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. The Journal of Pharmacology and Experimental Therapeutics. 274: 866-76. PMID 7636750 |
0.804 |
|
| 1995 |
Kirby LG, Kreiss DS, Singh A, Lucki I. Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum. Synapse (New York, N.Y.). 20: 99-105. PMID 7570349 DOI: 10.1002/Syn.890200202 |
0.816 |
|
| 1995 |
Kirby LG, Allen AR, Lucki I. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Research. 682: 189-96. PMID 7552310 DOI: 10.1016/0006-8993(95)00349-U |
0.776 |
|
| 1995 |
Kung MP, Essman WD, Frederick D, Meegalla S, Goodman M, Mu M, Lucki I, Kung HF. IPT: a novel iodinated ligand for the CNS dopamine transporter. Synapse (New York, N.Y.). 20: 316-24. PMID 7482291 DOI: 10.1002/Syn.890200405 |
0.806 |
|
| 1994 |
Lucki I, Singh A, Kreiss DS. Antidepressant-like behavioral effects of serotonin receptor agonists. Neuroscience and Biobehavioral Reviews. 18: 85-95. PMID 8170624 DOI: 10.1016/0149-7634(94)90039-6 |
0.843 |
|
| 1994 |
Neisewander JL, Lucki I, McGonigle P. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats. Synapse (New York, N.Y.). 16: 1-10. PMID 8134896 DOI: 10.1002/syn.890160102 |
0.376 |
|
| 1994 |
Kreiss DS, Lucki I. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. The Journal of Pharmacology and Experimental Therapeutics. 269: 1268-79. PMID 8014870 |
0.794 |
|
| 1994 |
Parry TJ, Eberle-Wang K, Lucki I, Chesselet MF. Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Experimental Neurology. 128: 181-90. PMID 7915675 DOI: 10.1006/exnr.1994.1126 |
0.354 |
|
| 1994 |
Shumsky JS, Lucki I. Differential regulation of the behavioral effects of chlordiazepoxide. Psychopharmacology. 115: 37-45. PMID 7862910 DOI: 10.1007/BF02244749 |
0.704 |
|
| 1994 |
Kirby LG, Rowan GA, Smith RL, Lucki I. Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM). Psychopharmacology. 113: 351-60. PMID 7862845 DOI: 10.1007/Bf02245209 |
0.796 |
|
| 1994 |
Essman WD, Singh A, Lucki I. Serotonergic properties of cocaine: effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine. Pharmacology, Biochemistry, and Behavior. 49: 107-13. PMID 7816859 DOI: 10.1016/0091-3057(94)90463-4 |
0.825 |
|
| 1994 |
Kreiss DS, Lucki I. Discriminative Stimulus Properties of the Serotonin Uptake Inhibitor Sertraline Experimental and Clinical Psychopharmacology. 2: 25-36. DOI: 10.1037//1064-1297.2.1.25 |
0.76 |
|
| 1993 |
Singh A, Lucki I. Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors. Neuropharmacology. 32: 331-40. PMID 8497336 DOI: 10.1016/0028-3908(93)90153-T |
0.602 |
|
| 1993 |
Wieland S, Fischette CT, Lucki I. Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors. Neuropharmacology. 32: 561-73. PMID 8393153 DOI: 10.1016/0028-3908(93)90052-5 |
0.671 |
|
| 1993 |
Neal-Beliveau BS, Joyce JN, Lucki I. Serotonergic involvement in haloperidol-induced catalepsy. The Journal of Pharmacology and Experimental Therapeutics. 265: 207-17. PMID 8386235 |
0.355 |
|
| 1993 |
Essman WD, McGonigle P, Lucki I. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine. Psychopharmacology. 112: 233-41. PMID 7871025 DOI: 10.1007/Bf02244916 |
0.794 |
|
| 1993 |
Kreiss DS, Wieland S, Lucki I. The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience. 52: 295-301. PMID 7680787 DOI: 10.1016/0306-4522(93)90157-B |
0.82 |
|
| 1992 |
Lucki I. 5-HT1 receptors and behavior. Neuroscience and Biobehavioral Reviews. 16: 83-93. PMID 1553109 DOI: 10.1016/S0149-7634(05)80055-7 |
0.465 |
|
| 1992 |
Robinson MB, Anegawa NJ, Gorry E, Qureshi IA, Coyle JT, Lucki I, Batshaw ML. Brain serotonin2 and serotonin1A receptors are altered in the congenitally hyperammonemic sparse fur mouse. Journal of Neurochemistry. 58: 1016-22. PMID 1531355 DOI: 10.1111/J.1471-4159.1992.Tb09356.X |
0.417 |
|
| 1992 |
Kreiss DS, Lucki I. Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT. Neuropharmacology. 31: 1073-6. PMID 1436390 DOI: 10.1016/0028-3908(92)90110-B |
0.808 |
|
| 1992 |
Subramaniam S, Lucki I, McGonigle P. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Brain Research. 571: 313-22. PMID 1351781 DOI: 10.1016/0006-8993(92)90670-5 |
0.367 |
|
| 1992 |
Rowan GA, Lucki I. Discriminative stimulus properties of the benzodiazepine receptor antagonist flumazenil. Psychopharmacology. 107: 103-12. PMID 1317039 DOI: 10.1007/Bf02244973 |
0.73 |
|
| 1991 |
Wieland S, Lucki I. Altered behavioral responses mediated by serotonin receptors in the genetically dystonic (dt) rat. Brain Research Bulletin. 26: 11-6. PMID 2015508 DOI: 10.1016/0361-9230(91)90185-M |
0.663 |
|
| 1991 |
Neisewander JL, Lucki I, McGonigle P. Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment. Brain Research. 558: 27-35. PMID 1933381 DOI: 10.1016/0006-8993(91)90710-D |
0.369 |
|
| 1991 |
Lucki I. Behavioral studies of serotonin receptor agonists as antidepressant drugs. The Journal of Clinical Psychiatry. 52: 24-31. PMID 1684363 |
0.364 |
|
| 1990 |
Lucki I, Wieland S. 5-Hydroxytryptamine1A receptors and behavioral responses. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 3: 481-93. PMID 2078281 |
0.629 |
|
| 1990 |
Lucki I, Kucharik RF. Increased sensitivity to benzodiazepine antagonists in rats following chronic treatment with a low dose of diazepam. Psychopharmacology. 102: 350-6. PMID 1979180 DOI: 10.1007/BF02244103 |
0.345 |
|
| 1990 |
Wieland S, Lucki I. Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test. Psychopharmacology. 101: 497-504. PMID 1975107 DOI: 10.1007/Bf02244228 |
0.671 |
|
| 1990 |
Wieland S, Kreider MS, McGonigle P, Lucki I. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine. Brain Research. 520: 291-302. PMID 1698505 DOI: 10.1016/0006-8993(90)91718-V |
0.661 |
|
| 1989 |
Lucki I, Ward HR, Frazer A. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. The Journal of Pharmacology and Experimental Therapeutics. 249: 155-64. PMID 2709329 |
0.573 |
|
| 1989 |
Rowan GA, Lucki I. Discrimination of the benzodiazepine receptor antagonist Ro 15-1788 using the conditioned taste aversion procedure. Nida Research Monograph. 95: 536. PMID 2561852 |
0.68 |
|
| 1989 |
Wieland S, Goodale D, Lucki I. Behavioral effects of 8-OH-DPAT: studies using the Microtaxic ventricular injector. Journal of Neuroscience Methods. 30: 151-9. PMID 2531256 DOI: 10.1016/0165-0270(89)90062-9 |
0.651 |
|
| 1988 |
Lucki I, Kreider MS, Simansky KJ. Reduction of feeding behavior by the serotonin uptake inhibitor sertraline. Psychopharmacology. 96: 289-95. PMID 3146763 DOI: 10.1007/BF00216052 |
0.72 |
|
| 1988 |
Lucki I, Kucharik RF. Selective enhancement of grooming behavior by the D-1 agonist SKF 38393 in rats following the destruction of serotonin neurons Annals of the New York Academy of Sciences. 525: 420-422. DOI: 10.1111/J.1749-6632.1988.Tb38631.X |
0.381 |
|
| 1987 |
Davidson TL, Lucki I. The long-term effects of diazepam and pentylenetetrazol on behavioral sensitivity to a stressor. Pharmacology, Biochemistry, and Behavior. 27: 99-103. PMID 3615553 DOI: 10.1016/0091-3057(87)90483-7 |
0.369 |
|
| 1987 |
Lucki I, Eberle KM, Minugh-Purvis N. The role of the aural head shake reflex in serotonin-mediated head shaking behavior. Psychopharmacology. 92: 150-6. PMID 3110836 DOI: 10.1007/BF00177907 |
0.455 |
|
| 1987 |
Davidson TL, Lucki I. Long-term effects of yohimbine on behavioral sensitivity to a stressor. Psychopharmacology. 92: 35-41. PMID 3110826 DOI: 10.1007/BF00215476 |
0.363 |
|
| 1987 |
Lucki I, Minugh-Purvis N. Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex. Brain Research. 420: 403-6. PMID 2960422 DOI: 10.1016/0006-8993(87)91265-0 |
0.451 |
|
| 1986 |
Winokur A, Lindberg ND, Lucki I, Phillips J, Amsterdam JD. Hormonal and behavioral effects associated with intravenous L-tryptophan administration. Psychopharmacology. 88: 213-9. PMID 3081933 DOI: 10.1007/Bf00652243 |
0.321 |
|
| 1985 |
Sills MA, Lucki I, Frazer A. Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP. Life Sciences. 36: 2463-9. PMID 4010463 DOI: 10.1016/0024-3205(85)90142-0 |
0.757 |
|
| 1985 |
Lucki I, Nobler MS. The acute effects of antidepressant drugs on the performance of conditioned avoidance behavior in rats. Pharmacology, Biochemistry, and Behavior. 22: 261-4. PMID 3983218 DOI: 10.1016/0091-3057(85)90388-0 |
0.408 |
|
| 1985 |
Lucki I, Frazer A. Performance and extinction of lever press behavior following chronic administration of desipramine to rats. Psychopharmacology. 85: 253-9. PMID 3923511 DOI: 10.1007/Bf00428183 |
0.511 |
|
| 1985 |
Frazer A, Lucki I, Sills M. Alterations in monoamine-containing neuronal function due to administration of antidepressants repeatedly to rats. Acta Pharmacologica Et Toxicologica. 56: 21-34. PMID 2984890 DOI: 10.1111/J.1600-0773.1985.Tb02496.X |
0.698 |
|
| 1985 |
Lucki I, moyer JA, Muth EA. Blockade of the anticonflict effects of lorazepam and diazepam by the monoamine oxidase inhibitor phenelzine Federation Proceedings. 44: No. 2770. |
0.591 |
|
| 1985 |
Sills MA, Lucki I, Frazer A. Development of selective behavioral tolerance following the repeated administration of serotonin agonists Federation Proceedings. 44: No. 4884. |
0.67 |
|
| 1984 |
Lucki I, Nobler MS, Frazer A. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. The Journal of Pharmacology and Experimental Therapeutics. 228: 133-9. PMID 6694097 |
0.561 |
|
| 1983 |
Heydorn WE, Lucki I, Frazer A. Continuous light paradoxically reduces catecholamine-induced melatonin production. Brain Research. 267: 175-8. PMID 6860943 DOI: 10.1016/0006-8993(83)91054-5 |
0.701 |
|
| 1983 |
Frazer A, Lucki I. Is the“new” more useful than the“old”? Behavioral and Brain Sciences. 6: 554-555. DOI: 10.1017/S0140525X00017404 |
0.426 |
|
| 1982 |
Lucki I, Frazer A. Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants. Psychopharmacology. 77: 205-11. PMID 6812141 DOI: 10.1007/Bf00464567 |
0.595 |
|
| 1982 |
Frazer A, Lucki I. Antidepressant drugs: effects on beta-adrenergic and serotonineregic receptors. Advances in Biochemical Psychopharmacology. 31: 69-90. PMID 6282067 |
0.449 |
|
| 1979 |
Lucki I, Harvey JA. Increased sensitivity to d- and l-amphetamine action after midbrain raphe lesions as measured by locomotor activity. Neuropharmacology. 18: 243-9. PMID 571542 DOI: 10.1016/0028-3908(79)90122-9 |
0.512 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1991 |
Lucki I, Marcoccia JM. Discriminated taste aversion with a 5-HT(1A) agonist measured using saccharin preference. Behavioural Pharmacology. 2: 335-344. PMID 11224077 |
0.296 |
|
| 1991 |
Neisewander JL, Lucki I, McGonigle P. Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats. The Journal of Pharmacology and Experimental Therapeutics. 257: 850-60. PMID 2033524 |
0.292 |
|
| 1987 |
Lucki I, Rickels K, Giesecke MA, Geller A. Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function. British Journal of Clinical Pharmacology. 23: 207-11. PMID 2881573 DOI: 10.1111/j.1365-2125.1987.tb03031.x |
0.286 |
|
| 1983 |
Lucki I. Rate-dependent effects of amphetamine on responding under random-interval schedules of reinforcement in the rat. Pharmacology, Biochemistry, and Behavior. 18: 195-201. PMID 6835978 DOI: 10.1016/0091-3057(83)90363-5 |
0.282 |
|
| 1983 |
Lucki I, DeLong RE. Control rate of response or reinforcement and amphetamine's effect on behavior. Journal of the Experimental Analysis of Behavior. 40: 123-32. PMID 6631311 DOI: 10.1901/jeab.1983.40-123 |
0.278 |
|
| 1997 |
Hemby SE, Lucki I, Gatto G, Singh A, Thornley C, Matasi J, Kong N, Smith JE, Davies HM, Dworkin SI. Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters. The Journal of Pharmacology and Experimental Therapeutics. 282: 727-33. PMID 9262336 |
0.276 |
|
| 1983 |
Amsterdam JD, Winokur A, Lucki I, Caroff S, Snyder P, Rickels K. A neuroendocrine test battery in bipolar patients and healthy subjects. Archives of General Psychiatry. 40: 515-21. PMID 6404232 DOI: 10.1001/archpsyc.1983.01790050041005 |
0.275 |
|
| 1983 |
Amsterdam JD, Winokur A, Abelman E, Lucki I, Rickels K. Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects. The American Journal of Psychiatry. 140: 907-9. PMID 6305216 DOI: 10.1176/Ajp.140.7.907 |
0.274 |
|
| 2014 |
Holt RI, de Groot M, Lucki I, Hunter CM, Sartorius N, Golden SH. NIDDK international conference report on diabetes and depression: current understanding and future directions. Diabetes Care. 37: 2067-77. PMID 25061135 DOI: 10.2337/Dc13-2134 |
0.273 |
|
| 1999 |
Lucki I. Genetic Models Of Antidepressant Drug Sensitivity In Knockout And Inbred Mouse Strains Behavioural Pharmacology. 10. DOI: 10.1097/00008877-199908001-00147 |
0.273 |
|
| 1988 |
Lucki I, Rickels K. The effect of anxiolytic drugs on memory in anxious subjects. Psychopharmacology Series. 6: 128-39. PMID 2905803 DOI: 10.1007/978-3-642-73288-1_9 |
0.272 |
|
| 1982 |
Amsterdam JD, Winokur A, Lucki I, Snyder P, Harris RI, Caroff S, Rickels K. Growth hormone, prolactin and thyrotropin responses to gonadotropin-releasing hormone in depressed patients and healthy volunteers. Psychoneuroendocrinology. 7: 177-84. PMID 6758014 DOI: 10.1016/0306-4530(82)90010-5 |
0.272 |
|
| 2010 |
Kilpatrick M, Church E, Danish S, Stiefel M, Jaggi J, Halpern C, Kerr M, Maloney E, Robinson M, Lucki I, Krizman-Grenda E, Baltuch G. Intracerebral microdialysis during deep brain stimulation surgery. Journal of Neuroscience Methods. 190: 106-11. PMID 20416339 DOI: 10.1016/J.Jneumeth.2010.04.013 |
0.27 |
|
| 1983 |
Amsterdam JD, Winokur A, Lucki I, Snyder P. Neuroendocrine regulation in depressed postmenopausal women and healthy subjects. Acta Psychiatrica Scandinavica. 67: 43-9. PMID 6405581 DOI: 10.1111/J.1600-0447.1983.Tb00329.X |
0.263 |
|
| 1986 |
Lucki I, Rickels K, Geller AM. Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology. 88: 426-33. PMID 2871579 DOI: 10.1007/BF00178503 |
0.263 |
|
| 1988 |
Lucki I, Kucharik R. Behavioral effects of benzodiazepine antagonists in rats treated chronically with diazepam Nida Research Monograph Series. 375. |
0.257 |
|
| 1993 |
Raynor K, Lucki I, Reisine T. Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats. The Journal of Pharmacology and Experimental Therapeutics. 265: 67-73. PMID 8097248 |
0.257 |
|
| 2001 |
Lucki I. A prescription to resist proscriptions for murine models of depression. Psychopharmacology. 153: 395-8. PMID 11271414 DOI: 10.1007/s002130000561 |
0.254 |
|
| 1988 |
Doty RL, Ferguson-Segall M, Lucki I, Kreider M. Effects of intrabulbar injections of 6-hydroxydopamine on ethyl acetate odor detection in castrate and non-castrate male rats. Brain Research. 444: 95-103. PMID 3129142 DOI: 10.1016/0006-8993(88)90917-1 |
0.253 |
|
| 1988 |
Lucki I. Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion. The Journal of Pharmacology and Experimental Therapeutics. 247: 1120-7. PMID 2974486 |
0.247 |
|
| 2020 |
Tsuda MC, Mahdi S, Namchuk A, Wu TJ, Lucki I. Vendor Differences in Anxiety-like Behaviors in Female and Male Sprague Dawley Rats. Physiology & Behavior. 113131. PMID 32791181 DOI: 10.1016/j.physbeh.2020.113131 |
0.229 |
|
| 1980 |
Edmon EL, Lucki I, Grisham MG. Choice responding following multiple schedule training Animal Learning & Behavior. 8: 287-292. DOI: 10.3758/BF03199608 |
0.225 |
|
| 2016 |
Steckler T, Curran HV, de Wit H, Howes O, Hoyer D, Lucki I, Miczek KA, Morrow AL, Price LH, Robbins TW. Editorial: Reporting guidelines for psychopharmacology. Psychopharmacology. PMID 26915651 DOI: 10.1007/S00213-016-4252-7 |
0.186 |
|
| 1986 |
Lucki I, Rickels K. The behavioral effects of benzodiazepines following long-term use. Psychopharmacology Bulletin. 22: 424-33. PMID 2877474 |
0.15 |
|
| 1997 |
Lucki I. Serotonergic mechanisms in models of depression Behavioural Pharmacology. 8: 654-655. DOI: 10.1097/00008877-199711000-00052 |
0.149 |
|
| 1989 |
Lucki I, Kerr LA, Fridman RB, Schweizer E, Rickels K. Behavioral effects of alprazolam in chronic therapeutic users. Nida Research Monograph. 95: 464. PMID 2701317 |
0.141 |
|
| 2003 |
Jones M, Lucki I. P.1.000 Sex differences in stress-induced depression European Neuropsychopharmacology. 13: S175. DOI: 10.1016/S0924-977X(03)91711-1 |
0.141 |
|
| 1995 |
Troy SM, Lucki I, Peirgies AA, Parker VD, Klockowski PM, Chiang ST. Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and diazepam. Journal of Clinical Pharmacology. 35: 410-9. PMID 7650232 |
0.138 |
|
| 2010 |
Lucki I. Genetic models of depression and antidepressant response Modern Trends in Pharmacopsychiatry. 27: 139-154. DOI: 10.1159/000319512 |
0.133 |
|
| 1985 |
Amsterdam JD, Lucki I, Winokur A. The ACTH stimulation test in depression. Psychiatric Medicine. 3: 91-100. PMID 3037614 |
0.127 |
|
| 2019 |
Cox BM, Cote TE, Lucki I. Addressing the Opioid Crisis: Medical Student Instruction in Opiate Drug Pharmacology and Pain Management. The Journal of Pharmacology and Experimental Therapeutics. PMID 31320493 DOI: 10.1124/Jpet.119.257329 |
0.101 |
|
| 1999 |
Rickels K, Lucki I, Schweizer E, GarcÃa-España F, Case WG. Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation. Journal of Clinical Psychopharmacology. 19: 107-13. PMID 10211911 DOI: 10.1097/00004714-199904000-00003 |
0.083 |
|
| 1986 |
Schweizer E, Rickels K, Lucki I. Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use. The New England Journal of Medicine. 314: 719-20. PMID 2869408 DOI: 10.1056/NEJM198603133141121 |
0.078 |
|
| 1983 |
Amsterdam JD, Winokur A, Lucki I, Snyder P. Hormone responses to GNRH. Psychoneuroendocrinology. 8: 351-3. PMID 6359220 DOI: 10.1016/0306-4530(83)90010-0 |
0.057 |
|
| 1992 |
troy s, piergies a, lucki i, parker v, chiang s. VENLAFAXINE PHARMACOKINETICS AND PHARMACODYNAMICS Clinical Neuropharmacology. 15: 324B. DOI: 10.1097/00002826-199202001-00628 |
0.051 |
|
| 1985 |
Lucki I, Rickels K, Geller AM. Psychomotor performance following the long-term use of benzodiazepines. Psychopharmacology Bulletin. 21: 93-6. PMID 2858909 |
0.041 |
|
| 1990 |
Lucki I, Volpicelli JR, Schweizer E. Differential craving between recovering abstinent alcoholic-dependent subjects and therapeutic users of benzodiazepines. Nida Research Monograph. 105: 322-3. PMID 1678864 |
0.02 |
|
| 2016 |
Lucki I. B. Kenneth Koe. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 41: 3119. PMID 27818509 DOI: 10.1038/npp.2016.152 |
0.016 |
|
| 1990 |
Lucki I, Volpicelli JR, Schweizer E. Differential craving between recovering abstinent alcoholic-dependent subjects and theapeutic users of benzodiazepines Nida Research Monograph Series. 322-323. |
0.014 |
|
| 1994 |
Lucki I, Sanberg PR. Preface Neuroscience and Biobehavioral Reviews. 18: 71. DOI: 10.1016/0149-7634(94)90037-X |
0.01 |
|
| Hide low-probability matches. |